Categories
Tags
recipientpatient hemovigilance - noninfectious adverse events
leukocytesincludes experimental transplantationimmunotherapy
recipientpatient hemovigilance - transfusion transmitted infec
leukocytes includes experimental transplantationimmunotherapy
cell biology immunology and biochemistry basic and preclinical
immunohematology and genetic testing red cells leukocytes and
Transfusion Medicine Clinical Practices and Trauma and Massive T
RecipientPatient Hemovigilance - Transfusion Transmitted Infect
recipientpatient hemovigilance-txn trans infectious diseases
Quality Management and Transfusion Medicine Clinical Practices
trainingeducation methods information technology it aka info
transfusion service platelets disorders trauma and massive tr
Biotherapies
DateOctober 23, 2024Credits1.5 General Continuing Education (GEN) | 1.5 Florida Lab Personnel (FLP) | 1.5 California Nurse (CN) | 1.5 California Lab Personnel (CLP)This session will delve into the critical elements of managing allogeneic cellular starting material for biotherapies…Moderator
Speakers
$30Standard PriceMembers save $5
DateOctober 23, 2024Credits1 General Continuing Education (GEN) | 1 Florida Lab Personnel (FLP) | 1 California Nurse (CN) | 1 California Lab Personnel (CLP)Oral abstracts about platelet storage…Speakers
Kathleen Kelly, PhDVitalant Innovation Center
University of Pittsburgh Department of Surgery
Andrey Skripchenko, PhDFDAModerators
Reuben Jacob, MDMedical Director Apheresis Service and Associate Director Transfusion Medicine/Blood Bank, Department of Pathology and Laboratory Medicine, Children's Healthcare of Atlanta, Assistant Professor, Department of Pediatrics, Emory University School of Medicine$30Standard PriceMembers save $5
DateOctober 23, 2024Credits1.5 General Continuing Education (GEN) | 1.5 Florida Lab Personnel (FLP) | 1.5 California Nurse (CN) | 1.5 California Lab Personnel (CLP) | 1.5 Physician (PHY)We all face challenges in our daily work activities within Apheresis and Cellular Therapy: What are the resources to help with suitability determination in donors with significant comorbidities? How to optimize HPC(A) and biotherapy collections? How to optimize collections for cellular therapy in p…Moderator
Vasiliki Kalodimou, CABP (H), MSc, PhDDirector at Flow Cytometry - Research & Regenerative Medicine Department, IASO Maternity & Research Hospital, Athens Greece, Assistant Professor, School of Medicine at the European University-Cyprus Ltd. Frankfurt Branch, Board/Committee on Research Ethi, IASO Maternity Hospital$30Standard PriceMembers save $5
